Veeva Systems, a cloud-based software provider for the life sciences industry, is forming a new 10-year strategic partnership agreement with Merck that builds on their existing 12-year partnership. Per the deal, Veeva will be providing Merck with a strategic pricing approach and Merck will have input into Veeva’s product roadmap.
According to the involved parties, the partnership helps accelerate Merck’s digital strategy and makes it more efficient for Merck to evaluate, purchase, operate, and create value from Veeva products and services.
“Transforming our digital, data, and analytics capabilities is integral to enabling our global colleagues to deliver on our purpose of using the power of leading-edge science to save and improve lives around the world,” says Robert M. Davis, CEO and president, Merck. “Our strategic partnership with Veeva expands our capacity to leverage innovative technology and enhances our ability to deliver value to patients and all our stakeholders.”
Read more about the deal here.